Zynex Inc. (OTCMKTS:ZYXI) – Equities research analysts at Seethru Equity lifted their FY2017 EPS estimates for shares of Zynex in a report issued on Wednesday. Seethru Equity analyst A. Tandon now forecasts that the company will post earnings per share of $0.21 for the year, up from their prior forecast of $0.20.
Zynex (OTCMKTS:ZYXI) last posted its quarterly earnings data on Monday, November 13th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.01. Zynex had a net margin of 24.10% and a negative return on equity of 248.78%. The company had revenue of $6.82 million for the quarter, compared to the consensus estimate of $5.52 million.
Zynex (ZYXI) opened at $3.70 on Thursday. The stock has a market cap of $119.84, a PE ratio of 28.46 and a beta of -0.10. Zynex has a twelve month low of $0.25 and a twelve month high of $4.00. The company has a current ratio of 1.27, a quick ratio of 1.19 and a debt-to-equity ratio of 0.02.
Zynex Company Profile
Zynex, Inc operates through the Electrotherapy and Pain Management Products segment. The Company conducts its business through its subsidiaries and the operating subsidiary is Zynex Medical, Inc (ZMI). Its other subsidiaries include Zynex Monitoring Solutions, Inc (ZMS) and Zynex Europe, ApS (ZEU). ZMI designs, manufactures and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation.
Receive News & Ratings for Zynex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zynex and related companies with MarketBeat.com's FREE daily email newsletter.